Business Context and Reporting Period
The Chemours Company (CC) filed a Form 8-K on November 6, 2025, to announce its third-quarter 2025 financial results. The filing serves as a notification that a press release and management prepared remarks have been issued regarding the period.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1) and prepared remarks (Exhibit 99.2), which are not included in the source text.
Material Changes
The filing text does not provide specific data on material changes versus the prior comparable period. It only confirms that the Company has issued results for the third quarter of 2025.
Guidance, Outlook, and Management Commentary
Senior management prepared remarks are attached as Exhibit 99.2. The Company scheduled a conference call for 8:00 a.m. Eastern Daylight Time on Friday, November 7, 2025, to discuss the results. An investor presentation and prepared remarks were scheduled to be posted on the investor relations website prior to the call. The filing explicitly states that the information furnished in the exhibits is not deemed "filed" for purposes of Section 18 of the Exchange Act and will not be incorporated by reference into other filings except as expressly set forth.
Investor Verification Checklist
- Review the full text of the press release (Exhibit 99.1) for specific Q3 2025 revenue and earnings figures.
- Examine the prepared remarks (Exhibit 99.2) for management's commentary on operational performance and future outlook.
- Access the investor presentation posted on investors.chemours.com for detailed financial tables and guidance updates.
- Verify the timing and content of the conference call scheduled for November 7, 2025.